跳至主要内容
临床试验/NCT02203292
NCT02203292已完成2 期

Transfusion Requirements After Head Trauma

University of Sao Paulo1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
44
试验地点
1
主要终点
Hemoglobin difference

研究概览

简要总结

TRAHT is a pilot randomized clinical trial designed to evaluate safety and feasibility of two red blood cells transfusion thresholds in moderate or severe traumatic brain injured patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age equal to or greater than 18 years
  • Moderate or severe traumatic brain injury, defined as Glasgow coma scale less than or equal to 12 at hospital admission
  • Hemoglobin lower than 9.0 g/dL within 7 days from hospital admission

排除标准

  • Glasgow coma scale equal to 3 with dilated pupils bilaterally
  • Previous neurological sequelae
  • Pregnant women
  • Jehovah's Witnesses
  • Hemorrhagic shock at randomization
  • Moribund patients
  • Unable to provide consent

结局指标

主要结局

Hemoglobin difference

时间窗: 14 days

Hemoglobin difference between restrictive and liberal groups

次要结局

  • 180 days mortality(Participants will be followed for 180 after hospital discharge)
  • Hospital mortality(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Number of transfused patients(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Number of red blood cell packages transfused(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Blood stream infection(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Extended Glasgow Outcome Scale at hospital discharge(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Pulsatility index(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Intensity of measures to reduce intracranial pressure(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Hospital length of stay(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Mechanical ventilation free days(28 days)
  • Acute Respiratory Distress Syndrome(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • ICU mortality(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Re-bleeding(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • ICU length of stay(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Extended Glasgow Outcome Scale after 6 months(180 days)
  • Myocardial Infarction(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Cerebral autoregulation(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)
  • Septic Shock(Participants will be followed for the duration of hospital stay, an expected average of 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

André Luiz Nunes Gobatto

M.D.

University of Sao Paulo

研究点 (1)

Loading locations...

相似试验